Literature DB >> 22023520

β-Catenin signaling: no relevance in Hodgkin lymphoma?

Kristina Sohlbach, Roland Moll, Jennifer Goßmann, Oxana Nowak, Peter Barth, Andreas Neubauer, Minh Quang Huynh.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22023520     DOI： 10.3109/10428194.2011.634046

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN： 1026-8022


× No keyword cloud information.
  6 in total

1.  WNT5A: a motility-promoting factor in Hodgkin lymphoma.

Authors:  F Linke; S Zaunig; M M Nietert; F von Bonin; S Lutz; C Dullin; P Janovská; T Beissbarth; F Alves; W Klapper; V Bryja; T Pukrop; L Trümper; J Wilting; D Kube
Journal:  Oncogene       Date:  2016-06-06       Impact factor: 9.867

Review 2.  Wnt signalling pathways in chronic lymphocytic leukaemia and B-cell lymphomas.

Authors:  Pavlína Janovská; Vítězslav Bryja
Journal:  Br J Pharmacol       Date:  2017-08-30       Impact factor: 8.739

3.  Canonical and non-canonical Wnt signal pathway in classic Hodgkin lymphoma and the prognostic significance of LEF1, β-catenin, FZD6 and Wnt5a/b.

Authors:  Linlin Gao; Wei Cui; Sarah Kelting; Janet Woodroof; Hua Li; Linheng Li; Da Zhang
Journal:  Am J Blood Res       Date:  2022-08-15

4.  Aberrant expression of homeobox gene SIX1 in Hodgkin lymphoma.

Authors:  Stefan Nagel; Corinna Meyer; Maren Kaufmann; Hans G Drexler; Roderick A F MacLeod
Journal:  Oncotarget       Date:  2015-11-24

Review 5.  Wnt Signaling in the Regulation of Immune Cell and Cancer Therapeutics.

Authors:  Muhammad Haseeb; Rameez Hassan Pirzada; Qurat Ul Ain; Sangdun Choi
Journal:  Cells       Date:  2019-11-03       Impact factor: 6.600

6.  Aberrantly Expressed OTX Homeobox Genes Deregulate B-Cell Differentiation in Hodgkin Lymphoma.

Authors:  Stefan Nagel; Stefan Ehrentraut; Corinna Meyer; Maren Kaufmann; Hans G Drexler; Roderick A F MacLeod
Journal:  PLoS One       Date:  2015-09-25       Impact factor: 3.240
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.